☆ 4.7 Editorial Material

Leveraging Adipocyte-Cardiomyocyte Signaling to Treat Ischemic Heart Failure

CIRCULATION RESEARCH (2022)

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association

Connie W. Tsao et al.

Summary: This article introduces the latest statistics on heart disease, stroke, and cardiovascular risk factors published by the American Heart Association in conjunction with the National Institutes of Health. The Statistical Update includes data on a range of clinical heart and circulatory disease conditions and their associated outcomes. It serves as a critical resource for the general public, policymakers, healthcare professionals, researchers, and others seeking the best available data.

CIRCULATION (2022)

Add to Collection
Review Cardiac & Cardiovascular Systems

Adiponectin and cardiometabolic trait and mortality: where do we go?

Albert Youngwoo Jang et al.

Summary: Adiponectin, a cytokine derived from adipocytes, has cardioprotective effects. While early and epidemiologic studies did not find a relationship between adiponectin and coronary artery disease, larger-scale studies reported a paradoxical increase in all-cause and cardiovascular mortality with higher adiponectin levels. The underlying mechanisms behind this paradox are still unclear. Differentiating between different subtypes of heart failure may help understand the adiponectin-mortality relationship. Mendelian randomization studies should be interpreted with caution due to potential confounding factors.

CARDIOVASCULAR RESEARCH (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Paul A. Heidenreich et al.

Summary: This article provides an overview of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure, including its aim, methods, and structure.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Add to Collection
Review Cardiac & Cardiovascular Systems

Adiponectin, Leptin and Cardiovascular Disorders

Shangang Zhao et al.

Summary: The discovery of leptin and adiponectin established adipose tissue as an important endocrine organ in cardiovascular health. Normal levels of adiponectin and leptin are crucial for proper cardiovascular function, while both excess and insufficient levels may contribute to cardiovascular disorders. High levels of both adiponectin and leptin are a paradoxical factor in the pathogenesis of cardiovascular diseases.

CIRCULATION RESEARCH (2021)

Add to Collection
Article Medicine, General & Internal

Estimating lifetime benefits of comprehensive disease -modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

Muthiah Vaduganathan et al.

LANCET (2020)

Add to Collection
Article Medicine, Legal

Forensic Analysis Reveals Acute Decompensation of Chronic Heart Failure in a 3500-Year-Old Egyptian Dignitary

Raffaella Bianucci et al.

JOURNAL OF FORENSIC SCIENCES (2016)

Add to Collection
Article Cardiac & Cardiovascular Systems

Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men:: Results from the 18-year follow-up of a large cohort from southern Germany

Wolfgang Koenig et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.